Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Elon Musk Says Tesla Cybercab and Optimus Production Will Start Slowly Before Rapid Growth 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Netflix Stock Slips After Earnings as Soft 2026 Guidance Overshadows Subscriber Milestone 
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board 
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes 
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty 
REDWOOD CITY, Calif., May 02, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report first quarter 2017 financial results after market close on Tuesday, May 9, 2017. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.
| Live Call: | U.S. | 855 890 8665 | |
| International | 720 634 2938 | ||
| Passcode | 14067412 | ||
| Live Webcast: | Codexis IR Website | ||
| The webcast will be archived for 30 days. | |||
| Replay: | U.S. | 855 859 2056 | |
| International | 404 537 3406 | ||
| Passcode | 14067412 | ||
| The replay will be available for 48 hours | |||
About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.
CONTACTS:
Investors
LHA
Jody Cain, 310 691 7100
[email protected]
